Develops drugs for various diseases and disorders.
Dec 2025Revenue $0.00/yrExpenses $38.6M/yr
No trend
Figures by year
When will Eupraxia Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $0.00 and expenses $38.6M.
| Fiscal year to | Revenue | Expenses | Pre-tax profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $38.6M | −$38.6M |
| Dec 2024 | $0.00 | $25.7M | −$25.7M |
| Dec 2023 | $0.00 | $28.9M | −$28.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.